JointsAid notes

Why week three is where most people quit

Ask anyone who has stopped taking a joint supplement when they stopped, and a surprising number will say the same thing: somewhere in the third week. The bottle is about half gone, nothing has obviously changed, and the daily capsule starts to feel like a small pointless chore.

That timing is not a coincidence, and it is not a sign the product failed. Three weeks is simply earlier than this category tends to show anything. The studies behind boswellia serrata and turmeric mostly run eight to twelve weeks before they measure an endpoint. The glucosamine trials that found anything at all ran longer still. Nobody designed those studies that way for fun — they ran long because shorter runs kept producing nothing to report.

So the practical advice is unglamorous. Decide before you start that you are going to judge it in week ten rather than week three, and pick a pack big enough that you are not re-deciding every thirty days. That is most of the reason the three bottle pack is the one most people take, and it is the whole reason the refund window runs to sixty days instead of thirty.

The other half of the problem is the chore itself. If the serving is sitting in a cupboard you open once a week, week three will win. Put it next to the coffee, the toothbrush or whatever else you genuinely do every morning. A supplement you take eleven days out of thirty is not being tested at all.

What a proprietary formulation does and does not tell you

“Proprietary formulation” is printed on an enormous number of supplement labels and it means something quite specific. It means the manufacturer declares one combined weight — 1,398 mg here — lists the ingredients underneath it, and does not publish how that weight is divided up.

It is legal, it is common, and there is a real commercial reason for it: the exact split is the part a competitor would copy. But it does remove the one number a careful buyer would most like to have.

Here is what you can still work out. Ingredients in that list are printed in descending order of weight. On this label glucosamine is first, so it carries the largest share of the 1,398 mg, and boswellia serrata is fifth, so it carries the smallest. That ordering is a requirement, not a courtesy.

Here is what you cannot work out. Whether “largest share” means 900 mg or 400 mg. Whether the fifth ingredient is present at a researched amount or at a token one. Two products with identical ingredient lists in identical order can be completely different products, and the label will not distinguish them.

None of this makes a proprietary formulation bad. It makes it unverifiable from the outside, which is a different complaint. It also means the sensible way to read our ingredient grades is as a statement about the ingredient, never about the dose in front of you.

The part a capsule cannot do for you

Every ingredient in this formula is researched as support alongside movement. Not one of them is studied as a replacement for it, and the distinction matters more than most supplement marketing lets on.

Joints are maintained largely by being used. Cartilage has no blood supply of its own, so the nutrients it needs are pushed in and the waste pushed out by load and release — walking, bending, standing up, sitting down. A joint that is rested completely gets stiffer, not better. That is why physiotherapy for a cranky knee is mostly exercises rather than rest.

Which puts a daily capsule in its proper place. At best it is the smaller half of the arrangement, and the larger half is unexciting: a walk most days, getting up from the desk more often than you want to, keeping range of motion at the joints that are complaining, and not letting body weight climb if you can help it.

If you are going to spend money on a joint supplement, the way to get the most out of it is to run it next to those things rather than instead of them. That is the sequence the four steps on the homepage describe, and it is also why the second step is not about the product at all.